FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

326364003: Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3699795016 Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3699796015 Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3699797012 Ethinyl estradiol 35 microgram and norgestimate 250 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
46718001000001116 Norgestimate 250microgram / Ethinylestradiol 35microgram tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module
60514501000001117 Ethinylestradiol 35microgram / Norgestimate 250microgram tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Ethinylestradiol 35mcg+progestogen false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Hormone false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Product containing ethinylestradiol and norgestimate false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Product containing estradiol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has basis of strength substance Norgestimate false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has basis of strength substance Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator value 35 false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator value 0.25 false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator value 0.035 false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has precise active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has precise active ingredient Norgestimate false Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Plays role Contraceptive therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has basis of strength substance Ethinylestradiol true Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has precise active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has precise active ingredient Norgestimate true Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has basis of strength substance Norgestimate true Inferred relationship Existential restriction modifier 2
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Ethinylestradiol + Norgestimate true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has specific active ingredient Norgestimate true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ethinylestradiol+norgestimate 35micrograms/250micrograms tablet - product Is a False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (Janssen-Cilag Ltd) Is a True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) Is a True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 126 tablet Is pack of False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Is pack of False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet Has VMP True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 126 tablet Has VMP True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Cilest 250microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) Is a True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Lizinna 250microgram/35microgram tablets (Morningside Healthcare Ltd) Is a True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (A A H Pharmaceuticals Ltd) Is a False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (AM Distributions (Yorkshire) Ltd) Is a False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Cilique 250microgram/35microgram tablets (Gedeon Richter (UK) Ltd) Is a True Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Is a False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Colorama Pharmaceuticals Ltd) Is a False Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start